Danaher Co. (DHR) Shares Sold by IBM Retirement Fund

Share on StockTwits

IBM Retirement Fund cut its holdings in Danaher Co. (NYSE:DHR) by 6.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,611 shares of the conglomerate’s stock after selling 725 shares during the period. IBM Retirement Fund’s holdings in Danaher were worth $1,094,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also bought and sold shares of the company. Robeco Institutional Asset Management B.V. boosted its holdings in Danaher by 44.9% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 133,342 shares of the conglomerate’s stock worth $14,492,000 after acquiring an additional 41,326 shares during the period. Stone Ridge Asset Management LLC boosted its holdings in Danaher by 15.8% in the 3rd quarter. Stone Ridge Asset Management LLC now owns 5,872 shares of the conglomerate’s stock worth $638,000 after acquiring an additional 800 shares during the period. JPMorgan Chase & Co. boosted its holdings in Danaher by 14.1% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,426,709 shares of the conglomerate’s stock worth $372,344,000 after acquiring an additional 424,317 shares during the period. MML Investors Services LLC boosted its holdings in Danaher by 12.4% in the 3rd quarter. MML Investors Services LLC now owns 9,864 shares of the conglomerate’s stock worth $1,072,000 after acquiring an additional 1,087 shares during the period. Finally, Commonwealth Bank of Australia boosted its stake in shares of Danaher by 2.2% during the 3rd quarter. Commonwealth Bank of Australia now owns 45,768 shares of the conglomerate’s stock valued at $4,967,000 after buying an additional 1,000 shares during the last quarter. 78.29% of the stock is owned by hedge funds and other institutional investors.

In other Danaher news, CAO Robert S. Lutz sold 17,822 shares of the stock in a transaction on Wednesday, February 27th. The stock was sold at an average price of $126.95, for a total value of $2,262,502.90. Following the sale, the chief accounting officer now directly owns 22,251 shares of the company’s stock, valued at $2,824,764.45. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Rainer Blair sold 37,859 shares of the stock in a transaction on Wednesday, February 27th. The stock was sold at an average price of $127.45, for a total value of $4,825,129.55. Following the completion of the sale, the insider now directly owns 32,661 shares in the company, valued at $4,162,644.45. The disclosure for this sale can be found here. Insiders sold 183,150 shares of company stock worth $23,279,637 over the last ninety days. 11.90% of the stock is owned by corporate insiders.

Shares of DHR opened at $128.69 on Friday. Danaher Co. has a 12-month low of $94.59 and a 12-month high of $129.42. The firm has a market cap of $90.32 billion, a P/E ratio of 28.47, a PEG ratio of 2.35 and a beta of 1.04. The company has a current ratio of 1.47, a quick ratio of 1.07 and a debt-to-equity ratio of 0.34.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, January 29th. The conglomerate reported $1.28 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.27 by $0.01. Danaher had a return on equity of 11.64% and a net margin of 13.33%. The firm had revenue of $5.40 billion for the quarter, compared to analysts’ expectations of $5.33 billion. During the same period last year, the business posted $1.19 earnings per share. The firm’s revenue for the quarter was up 6.2% on a year-over-year basis. As a group, analysts predict that Danaher Co. will post 4.76 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 26th. Investors of record on Friday, March 29th will be paid a dividend of $0.17 per share. The ex-dividend date of this dividend is Thursday, March 28th. This is a boost from Danaher’s previous quarterly dividend of $0.16. This represents a $0.68 annualized dividend and a yield of 0.53%. Danaher’s dividend payout ratio (DPR) is 14.16%.

DHR has been the subject of several research analyst reports. Needham & Company LLC reiterated a “buy” rating and set a $138.00 target price (up from $114.00) on shares of Danaher in a research note on Thursday, February 28th. Jefferies Financial Group raised their price objective on Danaher to $140.00 and gave the stock a “buy” rating in a research note on Tuesday, February 26th. Deutsche Bank raised their price objective on Danaher to $130.00 and gave the stock a “buy” rating in a research note on Tuesday, February 26th. UBS Group raised their price objective on Danaher from $125.00 to $144.00 and gave the stock a “buy” rating in a research note on Tuesday, February 26th. Finally, Janney Montgomery Scott upgraded Danaher from a “neutral” rating to a “buy” rating in a research note on Monday, February 25th. Two analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $123.31.

ILLEGAL ACTIVITY NOTICE: “Danaher Co. (DHR) Shares Sold by IBM Retirement Fund” was published by Equities Focus and is the property of of Equities Focus. If you are accessing this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark & copyright law. The correct version of this story can be read at https://www.equitiesfocus.com/2019/03/17/danaher-co-dhr-shares-sold-by-ibm-retirement-fund.html.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

Recommended Story: Diversification in Your Portfolio

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.